Where does Carlos Loya work?

Carlos Loya is Venture Partner & Founder at 82VS.

Where did Carlos Loya go to school?

Carlos Loya studied at Harvard Medical School (PhD, Neurobiology); New Mexico State University (BS, Biochemistry); University of Lausanne - UNIL (BS, Biochemistry and French).

Carlos Loya

Investor

Venture Partner & Founder at 82VS

Cambridge, Massachusetts, United States

About

Carlos Loya is a scientist and biotech executive who served as a founding team member at SAGE Therapeutics and Praxis Precision Medicines, where he contributed to the strategy, discovery, and development of multiple programs including Zulresso™ and Zurzuvae™, both of which received FDA approval. His expertise spans neuroscience and RNA biology, with professional experience in corporate development, licensing, partnerships, drug discovery strategy, and capital raising.

Experience

82VSVenture Partner2024 — 2026Greater Boston
82VSExecutive In Residence2021 — 2024Cambridge, Massachusetts, United States
Aldebaran TherapeuticsFounder & Board Member2022 — 2026Greater Boston
Alloy Therapeutics, Inc.Head of Partnering | Genetic Medicines2024 — 2025Greater Boston
Praxis Precision Medicines, Inc.Global Commercial Lead2020 — 2021Cambridge, Massachusetts, United States
Praxis Precision Medicines, Inc.Director of Corporate Development2018 — 2021Cambridge, Massachusetts, United States
Collegium Pharmaceutical, Inc.Associate Director of Corporate Development2016 — 2018Greater Boston
inVentiv Health - Campbell AllianceEngagement Manager, Corporate Development & Strategy Practice2014 — 2016Greater Boston
Sage TherapeuticsDrug Discovery and Porfolio Strategy2011 — 2014Cambridge, MA
Third Rock VenturesConsultant2011Boston, MA
Harvard Medical SchoolKirschstein & Ryan Graduate Research Fellow2005 — 2011Greater Boston
Siemens Venture CapitalBusiness Analyst Intern2010Greater Boston

Skills & more

Lifesciences31Biotechnology39Genetics20Neuroscience23Biochemistry15Entrepreneurship12Genomics9Drug Discovery20Genetic EngineeringMarket Analysis4Venture Capital2RNAi

+12 more

BiopharmaceuticalsLife SciencesCell CultureCommercializationPharmacologyMolecular BiologyPharmaceutical IndustryClinical DevelopmentStrategyNegotiationBusiness DevelopmentFinance

Languages English · French · Spanish

From Carlos's professional profile.

Colleagues at 82VS

Andrei Ramirez-Valdez

Venture Associate at 82VS

Andrew Peterson

Founder / EIR at 82VS

Arthur Suckow

Investor at 82VS

Caitlin Tolman

Chief Operating Officer at 82VS

Colby Jordan

Vice President, Capital Formation at 82VS

Dongxing Zha

Founder / EIR at 82VS

Errik Anderson

Board Director at Basecamp Fund

Hemanta Baruah

Founder / EIR at 82VS

Frequently asked questions

Who is Carlos Loya?: Carlos Loya is a scientist and biotech executive who served as a founding team member at SAGE Therapeutics and Praxis Precision Medicines, where he contributed to the strategy, discovery, and development of multiple programs including Zulresso™ and Zurzuvae™, both of which received FDA approval. His expertise spans neuroscience and RNA biology, with professional experience in corporate development, licensing, partnerships, drug discovery strategy, and capital raising.
Where does Carlos Loya work?: Carlos Loya is Venture Partner & Founder at 82VS.
Where did Carlos Loya go to school?: Carlos Loya studied at Harvard Medical School (PhD, Neurobiology); New Mexico State University (BS, Biochemistry); University of Lausanne - UNIL (BS, Biochemistry and French).

Founder mafias

Harvard Medical School mafia28

Also came through, then founded or led a company.

Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3 Lyle BerkowitzMedical informatics sub-fellowshipFounded Apollo Health +1 Rushika FernandopulleM.D.Founded Iora Health Kevin BittermanPh.D.Founded Editas Medicine Kush M ParmarMDFounded Homology Medicines Jeffrey M. JonasMDFounded Sage Therapeutics

+ 21 more

Third Rock Ventures mafia16

Also came through, then founded or led a company.

Reid HuberPartnerFounded MOMA Therapeutics +2 Christoph LengauerPartnerFounded Celsius Therapeutics +2 Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1 Alexis BorisyPartnerFounded Foundation Medicine +1 Philip ReillyVenture PartnerFounded Luna Genetics +1 Abbie CelnikerPartnerFounded Eleven Biotherapeutics

+ 9 more

82VS mafia8

Also came through, then founded or led a company.

Errik AndersonGeneral PartnerFounded Adimab +4 Andrew PetersonFounder / EIRFounded Aldebaran Therapeutics +1 Sudhir AgrawalAdvisorFounded Aldebaran Therapeutics Michael KalosAdvisorFounded IpiNovyx Bio Arthur SuckowAdvisorFounded DTx Pharma Ross LeimbergFounder / EIRFounded Cantai Therapeutics

+ 1 more

New Mexico State University mafia3

Also came through, then founded or led a company.

Yuzhe YanDoctor of Philosophy (Ph.D.)Founded LogisticsOS Alejandro RosasBachelor of Science - BS with HonorsFounded Didit

Sage Therapeutics mafia3

Also came through, then founded or led a company.

Steve PaulDirectorFounded Voyager Therapeutics, Inc. +1 Jamil BegSenior Director, Business Development & Brand LeaderFounded Nido Biosciences +1

Same school

Also attended Harvard Medical School143

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General Catalyst Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 137 more

Also attended New Mexico State University7

James SmithChief Growth Officer at IA Global Paula MarezGeneral Manager at FLYWHEEL Mike NolanInvestor at Walnut Venture Associates Beto PallaresFounder at Joseph Advisory Services Tammi SmorynskiManaging Director at Intel Capital Yuzhe YanFounder at LogisticsOS

+ 1 more

Also attended University of Lausanne - UNIL14

Pascal H. WidmerPartner at Alpana Ventures Alexander LangeFounding GP at Inflection.xyz Imed KhammariChief Risk Officer at Arab Bank (Switzerland)Ulrika KoppInvestment Manager at Procuritas Iván BustosPortfolio Analyst at Rockstart Christoph N. KossmannManager at Cipio Partners

+ 8 more

Shared employers

Also worked at Alloy Therapeutics, Inc.20

Jesse RobbinsFounder and Investor in AI Developer Tools Chaya PatelPrincipal at Mission Biocapital Errik AndersonBoard Director at Basecamp Fund Alasdair ThongFounding Partner at Selvedge Venture Esra BerkolChief of Staff at Selvedge Venture Mike SchmidtGeneral Partner, President and Head of 82VS Boston at 82VS

+ 14 more

+ 74 more

About

Experience

Skills & more

Colleagues at 82VS

Frequently asked questions

Founder mafias

Harvard Medical School mafia28

Third Rock Ventures mafia16

82VS mafia8

New Mexico State University mafia3

Sage Therapeutics mafia3

Same school

Also attended Harvard Medical School143

Also attended New Mexico State University7

Also attended University of Lausanne - UNIL14

Shared employers

Also worked at Alloy Therapeutics, Inc.20

Also worked at inVentiv Health - Campbell Alliance6

Also worked at Sage Therapeutics5

Also worked at Third Rock Ventures80